BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38375729)

  • 1. Effect of pulse methylprednisolone on prognosis in SARS-CoV-2 patients with severe pneumonia.
    Eraslan BZ; Fidan A; Baysal T; Cömert SS; Kıral N; Parmaksız ET
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):1234-1240. PubMed ID: 38375729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia.
    Pinzón MA; Ortiz S; Holguín H; Betancur JF; Cardona Arango D; Laniado H; Arias Arias C; Muñoz B; Quiceno J; Jaramillo D; Ramirez Z
    PLoS One; 2021; 16(5):e0252057. PubMed ID: 34033648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
    Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
    Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methylprednisolone pulse vs conventional dexamethasone for adult cases of COVID-19 requiring oxygen; a Japanese retrospective cohort study.
    Watanabe Y; Nakamura I; Sato S; Fujita H; Kobayashi T; Watanabe H
    J Infect Chemother; 2023 Mar; 29(3):269-273. PubMed ID: 36436740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit.
    Yaqoob H; Greenberg D; Hwang F; Lee C; Vernik D; Manglani R; Wang Z; Murad MH; Chandy D; Epelbaum O
    J Med Virol; 2022 Jan; 94(1):349-356. PubMed ID: 34542192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia.
    Aomar-Millán IF; Fatoul-Del Pino G; Torres-Parejo Ú; Pérez-Fernández L; Martínez-Diz S; Salvatierra J
    Med Clin (Barc); 2023 Feb; 160(4):156-159. PubMed ID: 35987733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients.
    Saeed MAM; Mohamed AH; Owaynat AH
    Egypt J Intern Med; 2022; 34(1):19. PubMed ID: 35194371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose pulse methylprednisolone vs. dexamethasone standard therapy for severe and critical COVID-19 pneumonia: Efficacy assessment in a retrospective single-centre experience from Malaysia.
    Soo CI; Poon KV; Ayub A; You HW; Tan CX; Loh KJJ; Eng CCH; Sia LC; Wong CK
    Med J Malaysia; 2024 Jan; 79(1):15-20. PubMed ID: 38287752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of equivalent doses of dexamethasone, methylprednisolone, and hydrocortisone for treatment of COVID-19-related acute respiratory distress syndrome: a prospective three-arm randomized clinical trial.
    Taher A; Lashkari M; Keramat F; Hashemi SH; Sedighi L; Poorolajal J; Mehrpooya M
    Wien Med Wochenschr; 2023 Apr; 173(5-6):140-151. PubMed ID: 36624180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients With COVID-19.
    Ko JJ; Wu C; Mehta N; Wald-Dickler N; Yang W; Qiao R
    J Intensive Care Med; 2021 Jun; 36(6):673-680. PubMed ID: 33632000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose glucocorticoids pulse-therapy for beta-coronaviridae pneumonia: a systematic literature review and case-series of Coronavirus disease-2019.
    Dolci G; Cassone G; Venturelli F; Besutti G; Revelli M; Corsini R; Sampaolesi F; Pavone P; Contardi G; Riva N; Marini G; Lazzaretti C; Mezzadri S; Milic J; Massari M; Costantini M; Salvarani C
    Clin Exp Rheumatol; 2021; 39(5):1119-1125. PubMed ID: 33635218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparison of the Effects of Dexamethasone and Methylprednisolone, Used on Level-3 Intensive Care COVID-19 Patients, on Mortality: A Multi-Center Retrospective Study.
    Sari A; Ekinci O; Saraçoğlu KT; Balık R; Aslan M; Balık Y; Önal C; Aslan M; Cevher S; Parmaksız A; Vatansever Ş; Çicek MC; Ayan ÖS; Şensöz Çelik G; Toprak A; Yılmaz M; Yurt E; Bakan N; Tekin S; Adıyeke E
    J Korean Med Sci; 2023 Jul; 38(29):e232. PubMed ID: 37489719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pulse steroid therapy in patients critically ill with COVID-19.
    Gundogdu O; Demir B; Coskun CO; Ersan I
    Bratisl Lek Listy; 2021; 122(11):793-798. PubMed ID: 34672670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of methylprednisolone treatment on COVID-19: An inverse probability of treatment weighting analysis.
    Porta L; Huang SS; Wei C; Su CH; Hsu WT; Sheng WH; Lee CC
    PLoS One; 2022; 17(6):e0266901. PubMed ID: 35714141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulse steroid treatment for hospitalized adults with COVID-19.
    Batırel A; Demirhan R; Eser N; Körlü E; Tezcan ME
    Turk J Med Sci; 2021 Oct; 51(5):2248-2255. PubMed ID: 33878858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid Pulse Therapy as a Treatment for Patients With COVID-19 Pneumonia at an Intensive Care Unit: A Single-Center Retrospective Observational Study.
    Okano H; Sakurai R; Yamazaki T
    Cureus; 2023 Mar; 15(3):e36386. PubMed ID: 36945235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FACTORS AFFECTING PROGNOSIS AND MORTALITY IN SEVERE COVID-19 PNEUMONIA PATIENTS.
    Afşin E; Demirkol ME
    Acta Clin Croat; 2023 Apr; 62(1):106-114. PubMed ID: 38304373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.